Concepedia

Yoshiko Awazu

YA

Statistics

Publications

6

Citations

323

H-Index

6

Active since

2010

Affiliations

Takeda (Japan)(Current)

Yoshiko Awazu is an author at Takeda (Japan) specializing in pharmacology, vegfr inhibitors, and medicinal chemistry.

Publications per year

2010–2013

6

Publications

6

Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: Novel VEGFR2 kinase inhibitors binding to inactive kinase conformation

Yuya Oguro, Naoki Miyamoto, Kengo Okada et al. · Bioorganic & Medicinal Chemistry · 2010 · 122 citations · Full text

, , +14

Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor

Naoki Miyamoto, Nozomu Sakai, Takaharu Hirayama et al. · Bioorganic & Medicinal Chemistry · 2013 · 72 citations · Full text

, , +10

Structure-based discovery of cellular-active allosteric inhibitors of FAK

Naoki Tomita, Yoko Hayashi, Shinkichi Suzuki et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 56 citations · Full text

, , +14

N-Phenyl-N′-[4-(5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as novel inhibitors of VEGFR and FGFR kinases

Yuya Oguro, Naoki Miyamoto, Terufumi Takagi et al. · Bioorganic & Medicinal Chemistry · 2010 · 28 citations · Full text

, , +11

A Novel Inhibitor of c-Met and VEGF Receptor Tyrosine Kinases with a Broad Spectrum of <i>In Vivo</i> Antitumor Activities

Yoshiko Awazu, Kazuhide Nakamura, Akio Mizutani et al. · Molecular Cancer Therapeutics · 2013 · 28 citations

, , +17

1–5 of 6